Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,477,524 papers from all fields of science
Search
Sign In
Create Free Account
cariprazine
Known as:
trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N',N'-dimethylurea hydrochloride
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Antipsychotic Agents
Schizophrenia Spectrum and Other Psychotic Disorders
cariprazine 1.5 MG Oral Capsule
Broader (1)
Piperazines
Narrower (2)
RGH-188
cariprazine hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
[Cariprazine for acute and maintenance treatment of schizophrenia].
S. K. Spoelstra
,
L. Visser
,
H. Knegtering
Tijdschrift voor psychiatrie
2019
Corpus ID: 210042081
BACKGROUND Since 2018, cariprazine has been available for the treatment of schizophrenia on the Dutch and Belgian markets. AIM…
Expand
2017
2017
What’s New in Bipolar Depression?
Chris B. Aiken
2017
Corpus ID: 132791927
Here: a plethora of treatment options, including mood-lifting stabilizers, non-antidepressants, psychotherapy, and lifestyle…
Expand
Review
2017
Review
2017
Update Psychopharmacotherapy.
G. Laux
Medizinische Monatsschrift fur Pharmazeuten
2017
Corpus ID: 49473565
Despite unmet meeds regarding efficacy, tolerability and time of onset and the high importance of mental disorders very few new…
Expand
2017
2017
New Drug Developments for Bipolar Mania December
Daniel C. Mathews
,
I. Henter
,
C. Zarate
2017
Corpus ID: 37767107
The disorder is frequently unrecognized, misdiagnosed, and not optimally managed. Moreover, no agent has been specifically…
Expand
2016
2016
Cariprazine for Schizophrenia and Bipolar I Disorder: As a Dopamine D3-Preferring D3/D2 Partial Agonist, Cariprazine Offers an Alternative to Antipsychotics That Preferentially Modulate D2 Receptors
G. Mattingly
,
Richard H. Anderson
2016
Corpus ID: 75969541
Cariprazine is a newly approved (September 2015) dopamine D3/D2 receptor partial agonist with higher affinity for the D3 receptor…
Expand
2016
2016
Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder : evidence for the efficacy of atypical antipsychotics
2016
Corpus ID: 51901618
2015
2015
Preparation method of cariprazine
许学农
2015
Corpus ID: 102912706
The invention discloses a preparation method of cariprazine (Cariprazine, RGH 188). The method includes the preparation steps of…
Expand
2015
2015
FDA approves cariprazine for treatment of schizophrenia
Erin Bastick
2015
Corpus ID: 58736107
FDA has approved cariprazine (Vraylar, Allergan and Gedeon Richter Plc.) for the treatment of schizophrenia and bipolar I…
Expand
2013
2013
pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
L. Citrome
2013
Corpus ID: 116077377
2012
2012
Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats
V. Román
,
I. Gyertyán
,
K. Sághy
,
B. Kiss
,
Z. Szombathelyi
Psychopharmacology
2012
Corpus ID: 253744405
Cariprazine (RGH-188) is a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate for the treatment of…
Expand